Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc., trading under ticker MAAQ, filed an 8-K current report with the SEC on October 15, 2025. The company emerged from a business combination with Mana Capital Acquisition Corp, a blank-check company sponsored by Mana Capital LLC that completed its IPO in 2021. Focused on the healthcare sector, specifically precision cardiovascular diagnostics powered by epigenetic biomarker technology, the post-merger entity operates in a specialized niche within the medical diagnostics industry. The October 2025 filing reflects the company's continued SEC reporting obligations following the completion of its SPAC transaction. Visit SpacDesk and sign up for full data, filings history, and deal analytics on MAAQ and hundreds of other SPAC transactions.